Oruka Therapeutics (ORKA) Operating Income Growth (5y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -15.67% |
| Mar 31, 2024 | -6.86% |
| Dec 31, 2023 | -18.36% |
| Sep 30, 2023 | -3.11% |
| Jun 30, 2023 | 1.76% |
| Mar 31, 2023 | 8.32% |
| Dec 31, 2022 | -16.98% |
| Sep 30, 2022 | 10.62% |
| Jun 30, 2022 | 10.35% |
| Mar 31, 2022 | 5.64% |
| Dec 31, 2021 | -5.76% |
| Sep 30, 2021 | -0.02% |
| Jun 30, 2021 | -4.18% |
| Mar 31, 2021 | -2.26% |
| Dec 31, 2020 | -10.05% |
| Sep 30, 2020 | 6.71% |
| Jun 30, 2020 | 13.59% |
| Mar 31, 2020 | 13.35% |
| Dec 31, 2019 | 13.32% |
| Sep 30, 2019 | 11.41% |
| Jun 30, 2019 | 8.92% |
| Mar 31, 2019 | 5.71% |
| Dec 31, 2018 | 29.71% |
| Sep 30, 2018 | 0.74% |
| Jun 30, 2018 | -12.47% |
| Mar 31, 2018 | -20.98% |
| Dec 31, 2017 | 32.80% |
| Sep 30, 2017 | -36.98% |
| Jun 30, 2017 | -37.16% |
| Mar 31, 2017 | -25.52% |
| Dec 31, 2016 | -21.31% |
| Sep 30, 2016 | -20.94% |
| Jun 30, 2016 | -18.26% |
| Mar 31, 2016 | -10.74% |
| Dec 31, 2015 | -6.18% |
| Sep 30, 2015 | -5.99% |
| Jun 30, 2015 | -3.68% |